| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2001;72:1887-1891
© 2001 The Society of Thoracic Surgeons
a Department of Cardiothoracic Transplantation, Papworth Hospital, Cambridge, United Kingdom
Accepted for publication July 6, 2001.
* Address reprint requests to Mr Wallwork, Department of Cardiothoracic Transplantation, Papworth Hospital, Papworth Everard, Cambridge CB3 8RE, UK
e-mail: john.wallwork{at}papworth-tr.anglox.nhs.uk
Background. Heart-lung transplantation (HLT) for Eisenmenger syndrome (ES) provides superior early and intermediate survival when compared with other forms of transplantation. The early risk factors and long-term outcome of HLT for ES are less well defined.
Methods. We analyzed 263 patients who had undergone HLT at our institution during more than 15 years. Fifty-one consecutive patients with ES who underwent HLT, 33 (65%) of which had simple anatomy, were compared with 212 cases having HLT for other indications (non-ES).
Results. Female sex and previous thoracotomy were more prevalent in the ES group. Patients with ES had greater postoperative blood loss and returned more frequently to the operating room for control of bleeding. There were 8 (16%) early deaths in the ES group compared with 27 (13%) in non-ES (p = 0.65). One-, 5-, and 10-year survival rates for ES were 72.6%, 51.3%, and 27.6%, respectively, compared with non-ES of 74.1%, 48.1%, and 26.0%, respectively, and there was no difference in survival overall (p = 0.54). Among ES patients, previous thoracotomy was a risk factor for hospital death. A subgroup analysis based on simple versus complex type of ES did not show statistically significant differences in terms of postoperative course or early or late survival.
Conclusions. Heart-lung transplantation is a successful procedure for ES. Despite a greater frequency of risk factors and a more difficult operative course, early and late outcome with HLT is comparable to non-ES recipients.
Related Article
Ann. Thorac. Surg. 2001 72: 1891.
This article has been cited by other articles:
|
|
 |
|
  M. Beghetti and N. Galie Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension. J. Am. Coll. Cardiol., March 3, 2009; 53(9): 733 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 National Pulmonary Hypertension Centres of the UK Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland Heart, March 1, 2008; 94(Suppl_1): i1 - i41. [Full Text] [PDF]
|
|
|
|
 |
|
 National Pulmonary Hypertension Centres of the UK Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland Thorax, March 1, 2008; 63(Suppl_2): ii1 - ii41. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Laks, D. Marelli, M. Plunkett, and J. Myers Adult Congenital Heart Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1431 - 1464. [Full Text]
|
|
|
|
|
|
A. Y. Sheikh, M. P. Pelletier, and R. C. Robbins Heart-Lung and Lung Transplantation Card. Surg. Adult, January 1, 2008; 3(2008): 1579 - 1608. [Full Text]
|
|
|
|
 |
|
 H. Goerler, A. Simon, B. Gohrbandt, C. Hagl, P. Oppelt, J. Weidemann, A. Haverich, and M. Strueber Heart lung and lung transplantation in grown-up congenital heart disease: long-term single centre experience Eur. J. Cardiothorac. Surg., December 1, 2007; 32(6): 926 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-P. Diller, K. Dimopoulos, H. Kafka, S. Y. Ho, and M. A. Gatzoulis Model of chronic adaptation: right ventricular function in Eisenmenger syndrome Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H54 - H60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-P. Diller and M. A. Gatzoulis Pulmonary Vascular Disease in Adults With Congenital Heart Disease Circulation, February 27, 2007; 115(8): 1039 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-R. Hosseinpour, S. Cullen, and V. T. Tsang Transplantation for adults with congenital heart disease. Eur. J. Cardiothorac. Surg., September 1, 2006; 30(3): 508 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S C Apostolopoulou, A Manginas, D V Cokkinos, and S Rammos Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease Heart, November 1, 2005; 91(11): 1447 - 1452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.M. Studer, R.D. Levy, K. McNeil, and J.B. Orens Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness Eur. Respir. J., October 1, 2004; 24(4): 674 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Laks, D. Marelli, M. Plunkett, J. Odim, and J. Myers Adult Congenital Heart Disease Card. Surg. Adult, January 1, 2003; 2(2003): 1329 - 1358. [Full Text]
|
|
|
|
|
|
L. B. Balsam, D. D. Yuh, R. C. Robbins, and B. A. Reitz Heart-Lung and Lung Transplantation Card. Surg. Adult, January 1, 2003; 2(2003): 1461 - 1490. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
